Can Gene Expression Analysis in Zero-Time Biopsies Predict Kidney Transplant Rejection?

Area of Science:

• Transplant immunology
• Genomics
• Renal transplantation

Background:

• Histological analysis of zero-time biopsies currently fails to predict kidney transplant outcomes.
• Gene expression profiling offers a potential method to identify predictive biomarkers.
• Understanding early molecular changes in donor kidneys is crucial for improving graft survival.

Purpose of the Study:

• To investigate the utility of gene expression analysis in zero-time kidney biopsies for predicting post-transplant complications.
• To compare gene expression profiles between living donor (LD) and deceased donor (DD) renal allografts.
• To identify specific gene expression patterns associated with different types of transplant rejection and graft dysfunction.

Main Methods:

• RNA isolation from formalin-fixed, paraffin-embedded (FFPE) zero-time biopsy sections.
• Gene expression profiling using quantitative methods.
• Correlation of gene expression data with clinical outcomes (rejection, delayed graft function) and cold ischemia time (CIT).
• Immunofluorescence microscopy to assess B-cell and plasma cell infiltration.

Main Results:

• Distinct gene expression profiles were observed between LD and DD zero-time biopsies.
• 185 differentially expressed genes were identified, with 68% correlating with CIT.
• Elevated immunoglobulin expression in zero-time biopsies was associated with subsequent T-cell mediated rejection (TCMR) and antibody-mediated rejection (ABMR).
• Immunoglobulin expression was increased in transplants with prior acute renal failure (ARF) but did not correlate with CIT.

Conclusions:

• Gene expression profiles in zero-time biopsies differ significantly between LD and DD kidney transplants.
• Pre-transplant ARF is associated with increased immunoglobulin expression in donor kidneys, potentially contributing to later rejection.
• Further validation in larger cohorts is needed to confirm these findings and clarify the role of early immunoglobulin upregulation in predicting transplant outcomes.